Financing round-up: HBOX Therapies, Resalis Therapeutics, Eluminex Biosciences, Angiodroid, VisionHealth

Germany: VisionHealth, a digital therapeutics company focused on enhancing inhaled treatment of chronic lung diseases, has closed a €3m pre-series A financing led by DB Speciality Invest, the investment firm owned by life science entrepreneur Dr Dietrich Bruchmann. He will take a seat on the non-executive board. Funds will be used to finance a second…

You must be a HMI Subscriber to view this content.

Subscribe Now »